U.S. Anticoagulant And Antiplatelet Therapies Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report provides revenue forecasts, market shares, projected incidence and prevalence numbers, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely anticoalugants and antiplatelets, each sub-segmented into oral and injection markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.

Table of Contents

U.S. Anticoagulant And Antiplatelet Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Anticoagulant And Antiplatelet Therapies Markets, IntroductionOverviewScope and SegmentationTherapeutic OverviewDisease OverviewEconomic Impact of Cardiovascular DiseasesChallenges and StrategiesMarket DynamicsDemand Analysis - IDemand Analysis - IIMarket and Technology TrendsRevenue ForecastFrost & Sullivan Market Engineering AwardsMarket Engineering Leadership: Bristol-Myers Squibb Sanofi Pharmaceuticals Holding PartnershipTechnology Leadership: Sanofi-SynthelaboBusiness Development Strategy : Aventis PharmaceuticalsTechnology Innovation: AstraZenecaMerger & Acquisition Strategy: Bristol-Myers SquibbU.S. Anticoagulant And Antiplatelet Therapies Markets, Anticoagulant Therapies MarketOverviewIntroductionMarket Engineering AnalysisRevenue ForecastCompetitive AnalysisCompetitive StructureMarket Share AnalysisOral Anticoagulant Therapies MarketIntroductionDriversRestraintsMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingInjection Anticoagulant Therapies MarketIntroductionDriversRestraintsMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-Lovenox Product Analysis-ArixtraProduct Analysis-EmergingU.S. Anticoagulant And Antiplatelet Therapies Markets, Antiplatelet Therapies MarketOverviewIntroductionMarket Engineering AnalysisRevenue ForecastCompetitive AnalysisCompetitive StructureMarket Share AnalysisOral Antiplatelet Therapies MarketIntroductionDriversRestraintsMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingInjection Antiplatelet Therapies MarketIntroductionDriversRestraintsMarket Engineering AnalysisRevenue ForecastPricing TrendsCompetitive StructureMarket Share AnalysisProduct Analysis




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.